EDMONTON, Feb. 18 /CNW/ - Isotechnika Pharma Inc. (TSX:ISA) is pleased
to announce that Dr. Peter Wijngaard, Vice President, Innovation
Leader, Research & Development at The Medicines Company, and Dr.
Heung-Joon Yang, President, Global Network Services, Inc. have today
joined the Board of Directors.
Isotechnika's President & CEO, Dr. Robert Foster commented, "We are
excited to welcome these two highly qualified individuals to our
Board. They both have a strong depth of relevant experience that can
help Isotechnika as we move into Phase 3 for the prevention of kidney
transplant rejection and progress our corporate development
Dr. Wijngaard holds a Ph.D. in Immunology from Utrecht University, The
Netherlands. Dr. Wijngaard formerly worked for F. Hoffmann-La Roche
Ltd. (Basel, Switzerland.) as the Life Cycle Leader Transplantation for
voclosporin, Cellcept, Zenapax, and DAC HYP. Dr. Wijngaard's past
experience with the development of voclosporin in conjunction with his
pharmaceutical industry background will be very beneficial to the
Dr. Yang holds a Ph.D. in Bioengineering from University of Washington
(Seattle, Washington, USA) and was the former CEO of LG Life Sciences,
Ltd. Dr. Yang has a great deal of experience with cyclosporine
analogues and has an in depth understanding of the Company's lead
Both Dr. Wijngaard and Dr. Yang will serve on the Board's Audit
Committee. To facilitate the appointment of the new members, Mr.
Franklin Berger and Dr. Jurgen Engel have officially agreed to step
down from the Company's Board of Directors effective immediately. The
Company and the Board thank them both for their service as Directors.
About Isotechnika Pharma Inc.
Isotechnika Pharma Inc. is a biopharmaceutical company focused on the
discovery and development of immunomodulating therapeutics designed to
offer key safety advantages over currently available treatments. Its
lead drug, voclosporin, is a calcineurin inhibitor, and is targeted at
the estimated $3.0 billion market for this class of immunosuppressants.
Isotechnika Pharma Inc. is a publicly traded company on the Toronto
Stock Exchange under the symbol "ISA". More information on Isotechnika
Pharma can be found at www.isotechnika.com or www.SEDAR.com.
We seek safe harbor.
SOURCE Isotechnika Pharma Inc.
For further information: